The following bills will be considered at the markup:
- S. 1067, Ensuring Timely Access to Generics Act of 2023
- S. 1114, Expanding Access to Low-Cost Generics Act of 2023
- S. 1214, RARE Act
- S. 1339, Pharmacy Benefit Manager Reform Act
Original source can be found here